Inhibiting the P2X7R-NLRP3 inflammasome pathway regulates CXCL16 to alleviate podocyte injury in mice with adriamycin nephropathy. [PDF]
Zhu Y +6 more
europepmc +1 more source
MYO1C is a urinary extracellular vesicle biomarker and mediator of podocyte injury in diabetic nephropathy. [PDF]
Zhao Z +10 more
europepmc +1 more source
Histone methyltransferase EZH2 drives podocyte injury and senescence in diabetic nephropathy through STAT3 activation. [PDF]
He M +9 more
europepmc +1 more source
FOS drives podocyte injury and renal fibrosis in diabetic kidney disease via direct Smad3 binding. [PDF]
Sun M, Yan T, Zhao W, Cheng Z.
europepmc +1 more source
CYBB-Mediated Ferroptosis Drives Podocyte Injury in Lupus Nephritis and Represents a Therapeutic Target. [PDF]
Wang B +9 more
europepmc +1 more source
Nucleophosmin Promotes Regulated Cell Death in Podocyte Injury. [PDF]
Urae S +6 more
europepmc +1 more source
Baicalin ameliorates podocyte injury and renal function impairment in idiopathic membranous nephropathy by inhibiting the AGE/RAGE signaling. [PDF]
Lou C +6 more
europepmc +1 more source
Impaired glycolysis-derived serine metabolism as a key driver of podocyte injury with senescence. [PDF]
Hu H +12 more
europepmc +1 more source
ZhiXiaoSanZheng formula ameliorates podocyte injury in diabetic kidney disease by inhibiting ferroptosis: integrated network pharmacology and experimental validation. [PDF]
Zhou S +10 more
europepmc +1 more source

